ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |
| Rock Springs Capital Management LP | 3,960,449 | $27,129,076 | 0.73% |
| Vivo Capital, LLC | 898,631 | $6,155,622 | 0.67% |
| RA Capital Management | 4,398,453 | $30,129,403 | 0.59% |
| ACUTA CAPITAL PARTNERS, LLC | 121,692 | $833,590 | 0.56% |
| CAXTON CORP | 19,473 | $133,387 | 0.51% |
| Affinity Asset Advisors, LLC | 260,000 | $1,781,000 | 0.50% |
| Ikarian Capital, LLC | 5,955 | $4,079,175 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 199,000 | $1,363,150 | 0.41% |
| Lion Point Capital, LP | 115,898 | $793,901 | 0.35% |
| Ikarian Capital, LLC | 3,637 | $2,491,345 | 0.30% |
External links
This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.